This study was conducted to evaluate the amount of weight loss and weight regain and also remission rate of obesity-related comorbidities including diabetes mellitus (DM), hypertension (HTN), and dyslipidemia in patients who underwent LRYGB or LSG during 5 years of follow-up.
A total of 120 patients who underwent LRYGB or LSG from 2011 to 2013 were enrolled and followed-up for 5 years. Changes in weight, body mass index (BMI), percent weight loss (%WL), and percentage of excess weight loss (%EWL) were recorded.
%WL and %EWL were similar between two procedures at 1 year following operation. In patients who underwent LSG, %WL and %EWL were 24.6 ± 1.3% and 61.9 ± 3.5%, respectively, and in LRYGB were 30.4 ± 1.3% and 79.4 ± 3.6%, respectively, 5 years after surgery. Weight regain was 32.0% in LSG and 9.3% in LRYGB after 5 years. The remission rate of diabetes mellitus, hypertension, and dyslipidemia was 70%, 54%, and 100%, respectively, after 5 years of surgery.
Comparing the 5-year success rate of these two techniques, LRYGB seems to be superior to LSG, with lower weight regain and higher weight loss. The short- and long-term effects of two procedures on remission of comorbidities were comparable.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price includes VAT (USA)
Tax calculation will be finalised during checkout.
Hruby A, Hu FB. The epidemiology of obesity: a big picture. Pharmacoeconomics. 2015;33:673–89.
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017;390:2627–42.
Kelly T, Yang W, Chen CS, et al. Global burden of obesity in 2005 and projections to 2030. Int J Obes. 2008;32:1431–7.
Esteghamati A, Khalilzadeh O, Mohammad K, et al. Secular trends of obesity in Iran between 1999 and 2007: National Surveys of risk factors of non-communicable diseases. Metab Syndr Relat Disord. 2010;8:209–13.
Hosseinpanah F, Barzin M, Amiri P, et al. The trends of metabolic syndrome in normal-weight Tehranian adults. Ann Nutr Metab. 2011;58:126–32.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.
Stenard F, Iannelli A. Laparoscopic sleeve gastrectomy and gastroesophageal reflux. World J Gastroenterol. 2015;21:10348–57.
Li Z, Bowerman S, Heber D. Health ramifications of the obesity epidemic. Surg Clin North Am. 2005;85:681–701.
Capoccia D, Coccia F, Guarisco G, et al. Long-term metabolic effects of laparoscopic sleeve gastrectomy. Obes Surg. 2018;28:2289–96.
Fuchs T, Loureiro M, Both GH, et al. The role of the sleeve gastrectomy and the management of type 2 diabetes. Arq Bras Cir Dig. 2017;30:283–6.
Golzarand M, Toolabi K, Farid R. The bariatric surgery and weight losing: a meta-analysis in the long-and very long-term effects of laparoscopic adjustable gastric banding, laparoscopic roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy on weight loss in adults. Surg Endosc. 2017;31:4331–45.
Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934.
Dakour Aridi H, Khazen G, Safadi BY. Comparison of outcomes between laparoscopic roux-en-Y gastric bypass and sleeve gastrectomy in a Lebanese bariatric surgical practice. Obes Surg. 2018;28:396–404.
Jirapinyo P, Abu Dayyeh BK, Thompson CC. Weight regain after roux-en-Y gastric bypass has a large negative impact on the bariatric quality of life index. BMJ Open Gastroenterol. 2017;4:e000153.
Cummings DE, Cohen RV. Beyond BMI: the need for new guidelines governing the use of bariatric and metabolic surgery. Lancet Diabetes Endocrinol. 2014;2:175–81.
Golzarand M, Toolabi K, Hedayati M, Azam K, Douraghi M, Djafarian K. Comparative study of resting metabolic rate and plasma amino acid profile in patients who underwent laparoscopic roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: 6-month follow-up study. Obes Surg. 2019
Toolabi K, Arefanian S, Golzarand M, et al. Effects of laparoscopic roux-en-Y gastric bypass (LRYGB) on weight loss and biomarker parameters in morbidly obese patients: a 12-month follow-up. Obes Surg. 2011;21:1834–42.
Baig SJ, P P, Mahawer KK, et al. Weight regain after bariatric surgery-a multicenter study of 9617 patients from Indian bariatric surgery outcome reporting group. Obes Surg. 2019;29:1583–92.
Fleiss JL. Design and analysis of clinical experiments: John Wiley & Sons; 2011.
Brethauer SA, Aminian A, Romero-Talamas H, et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258:628–36.
Bhandari M, Reddy M, Kosta S, et al. Laparoscopic sleeve gastrectomy versus laparoscopic gastric bypass: a retrospective cohort study. Int J Surg. 2019;67:47–53.
Leyba JL, Llopis SN, Aulestia SN. Laparoscopic roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the treatment of morbid obesity. A prospective study with 5 years of follow-up. Obes Surg. 2014;24:2094–8.
Cooper TC, Simmons EB, Webb K, et al. Trends in weight regain following roux-en-Y gastric bypass (RYGB) bariatric surgery. Obes Surg. 2015;25:1474–81.
Bohdjalian A, Langer FB, Shakeri-Leidenmuhler S, et al. Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin. Obes Surg. 2010;20:535–40.
King WC, Hinerman AS, Belle SH, et al. Comparison of the performance of common measures of weight regain after bariatric surgery for association with clinical outcomes. JAMA. 2018;320:1560–9.
Alvarez V, Carrasco F, Cuevas A, et al. Mechanisms of long-term weight regain in patients undergoing sleeve gastrectomy. Nutrition. 2016;32:303–8.
Courcoulas AP, King WC, Belle SH, et al. Seven-year weight trajectories and health outcomes in the longitudinal assessment of bariatric surgery (LABS) study. JAMA Surg. 2018;153:427–34.
Inge TH, Courcoulas AP, Jenkins TM, et al. Weight loss and health status 3 years after bariatric surgery in adolescents. N Engl J Med. 2016;374:113–23.
Peterli R, Wolnerhanssen B, Vetter D, et al. Laparoscopic sleeve gastrectomy versus roux-en-Y gastric bypass for morbid obesity-3-year outcomes of the preospective randomized Swiss multicenter bypass or sleeve study (SM-BOSS). Ann Surg. 2017;265:446–73.
Dicker D, Yahalom R, Comaneshter DS, et al. Long-term outcomes of three types of bariatric surgery on obesity and type 2 diabetes control and remission. Obes Surg. 2016;26:1814–20.
Salminen P, Helmio M, Ovaska J, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial. JAMA. 2018;319:241–54.
Ricci C, Gaeta M, Rausa E, et al. Early impact of bariatric surgery on type II diabetes, hypertension, and hyperlipidemia: a systematic review, meta-analysis and meta-regression on 6,587 patients. Obes Surg. 2014;24:522–8.
The authors acknowledged Mrs. Roya Farid for critical editing of English grammar of the manuscript.
The study protocol was approved by the Ethics Committee of Tehran University of Medical Sciences (No. 9311245004), and informed consent was obtained from all the participants.
Conflict of Interest
The authors declare that they have no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Toolabi, K., Sarkardeh, M., Vasigh, M. et al. Comparison of Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Sleeve Gastrectomy on Weight Loss, Weight Regain, and Remission of Comorbidities: A 5 Years of Follow-up Study. OBES SURG 30, 440–445 (2020). https://doi.org/10.1007/s11695-019-04183-x
- Gastric bypass
- Sleeve gastrectomy
- Weight loss
- Weight regain